FDA Drug Recalls

Recalls / Class III

Class IIID-1155-2014

Product

Carisoprodol Tablets, USP, 350 mg, unit dose blister packages of 100 tablets (10 cards of 10 tablets each), Rx only, Manufactured for: Qualitest Pharmaceuticals, Huntsville, AL NDC 51079-819-20

Affected lot / code info
Lots and Expiration Dates: 3037463, Expires 2/2014; 3039466, Expires 3/2014; 3040644, Expires 4/2014; 3043463, Expires 6/2014; 3049568, Expires 3/2015

Why it was recalled

Failed Impurity/degradation Specification

Recalling firm

Firm
Mylan Institutional, Inc. (d.b.a. UDL Laboratories)
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
1718 Northrock Ct, N/A, Rockford, Illinois 61103-1201

Distribution

Quantity
3,252 cartons
Distribution pattern
US: Nationwide

Timeline

Recall initiated
2014-01-28
FDA classified
2014-03-12
Posted by FDA
2014-03-19
Terminated
2015-06-19
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1155-2014. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class III recall: drug · FDA Drug Recalls